These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27377124)

  • 1. In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MS.
    Liu B; Guo H; Zhang J; Xue J; Yang Y; Qin T; Xu J; Guo Q; Zhang D; Qian W; Li B; Hou S; Dai J; Guo Y; Wang H
    Mol Pharm; 2016 Aug; 13(8):2702-10. PubMed ID: 27377124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry.
    Wang L; Amphlett G; Blättler WA; Lambert JM; Zhang W
    Protein Sci; 2005 Sep; 14(9):2436-46. PubMed ID: 16081651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
    Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Characterization of a Monoclonal Antibody-Maytansinoid Immunoconjugate.
    Luo Q; Chung HH; Borths C; Janson M; Wen J; Joubert MK; Wypych J
    Anal Chem; 2016 Jan; 88(1):695-702. PubMed ID: 26629796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.
    Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H
    Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
    Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
    Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
    Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.
    Beck A; Terral G; Debaene F; Wagner-Rousset E; Marcoux J; Janin-Bussat MC; Colas O; Van Dorsselaer A; Cianférani S
    Expert Rev Proteomics; 2016; 13(2):157-83. PubMed ID: 26653789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis.
    Janin-Bussat MC; Dillenbourg M; Corvaia N; Beck A; Klinguer-Hamour C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():9-13. PubMed ID: 25596378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion.
    Wagner-Rousset E; Janin-Bussat MC; Colas O; Excoffier M; Ayoub D; Haeuw JF; Rilatt I; Perez M; Corvaïa N; Beck A
    MAbs; 2014; 6(1):273-85. PubMed ID: 24135617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate determination of drug-to-antibody ratio of interchain cysteine-linked antibody-drug conjugates by LC-HRMS.
    Li K; Zhang Z; Lin ZJ; Shi H; Ma Y
    Anal Bioanal Chem; 2020 Feb; 412(4):833-840. PubMed ID: 31872274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry.
    Hernandez-Alba O; Houel S; Hessmann S; Erb S; Rabuka D; Huguet R; Josephs J; Beck A; Drake PM; Cianférani S
    J Am Soc Mass Spectrom; 2019 Nov; 30(11):2419-2429. PubMed ID: 31429052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
    Chapel S; Rouvière F; Sarrut M; Heinisch S
    Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
    Friese OV; Smith JN; Brown PW; Rouse JC
    MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection.
    Stoll D; Danforth J; Zhang K; Beck A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():51-60. PubMed ID: 27267072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
    Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
    Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical techniques for the characterization of Antibody Drug Conjugates: Challenges and prospects.
    Neupane R; Bergquist J
    Eur J Mass Spectrom (Chichester); 2017 Dec; 23(6):417-426. PubMed ID: 29183195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.